{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T07:33:04Z","timestamp":1785569584471,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijrobp.2024.10.008","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T23:55:29Z","timestamp":1729122929000},"page":"991-999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-Term Outcomes of Ocular and Visual Preservation After Carbon Ion Radiation Therapy for Choroidal Malignant Melanoma"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8646-9448","authenticated-orcid":false,"given":"Shuri","family":"Aoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3017-2017","authenticated-orcid":false,"given":"Masaru","family":"Wakatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Makishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenobu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinobu","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Mizota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.10.008_bib0001","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/OPTH.S89591","article-title":"Uveal melanoma: Epidemiology, etiology, and treatment of primary disease","volume":"11","author":"Krantz","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0002","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/CMR.0000000000000375","article-title":"Characteristics of melanoma in Japan: A nationwide registry analysis 2011-2013","volume":"27","author":"Tomizuka","year":"2017","journal-title":"Melanoma Res"},{"issue":"1","key":"10.1016\/j.ijrobp.2024.10.008_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"- Ophthalmic Oncology Task Force. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0004","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamaophthalmol.2014.111","article-title":"Plaque radiotherapy for juxtapapillary choroidal melanoma: Treatment complications and visual outcomes in 650 consecutive cases","volume":"132","author":"Sagoo","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0005","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s11864-024-01212-5","article-title":"External beam radiotherapy in the management of uveal melanoma","volume":"25","author":"Yilmaz","year":"2024","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0006","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2015.01.029","article-title":"Long-term results of the UCSF-LBNL randomized trial: Charged particle with helium ion versus iodine-125 plaque therapy for choroidal and ciliary body melanoma","volume":"92","author":"Mishra","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0007","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2307\/3579446","article-title":"Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy","volume":"147","author":"Kanai","year":"1997","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0008","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ijrobp.2006.09.022","article-title":"Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: A phase I\/II dose-escalation study","volume":"67","author":"Tsuji","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0009","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/09553000903072470","article-title":"Biological characteristics of carbon-ion therapy","volume":"85","author":"Ando","year":"2009","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0010","first-page":"46","article-title":"Enucleation after stereotactic radiosurgery in patients with uveal melanoma","volume":"76","author":"Zahorjanov\u00e1","year":"2020","journal-title":"Cesk Slov Oftalmol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0011","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/aos.12731","article-title":"Risk factors associated with secondary enucleation after fractionated stereotactic radiotherapy in uveal melanoma","volume":"93","author":"van den Bosch","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0012","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.3390\/curroncol30070470","article-title":"Radiotherapy in uveal melanoma: A review of ocular complications","volume":"30","author":"Banou","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0013","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0360-3016(00)01430-9","article-title":"Proton radiation therapy for medium and large choroidal melanoma: Preservation of the eye and its functionality","volume":"49","author":"Fuss","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0014","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0360-3016(02)04200-1","article-title":"Eye retention after proton beam radiotherapy for uveal melanoma","volume":"55","author":"Egger","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0015","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2005.01.016","article-title":"Proton beam radiotherapy of choroidal melanoma: The Liverpool-Clatterbridge experience","volume":"62","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0016","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/0284186X.2020.1820572","article-title":"Hypofractionated stereotactic photon radiotherapy of choroidal melanoma: 20-year experience","volume":"60","author":"Eibenberger","year":"2021","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.ijrobp.2024.10.008_bib0017","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ijrobp.2006.08.080","article-title":"Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis","volume":"67","author":"Hirasawa","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ijrobp.2024.10.008_bib0018","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijrobp.2012.12.022","article-title":"Long-term results of carbon ion radiation therapy for locally advanced or unfavorably located choroidal melanoma: usefulness of CT-based 2-port orthogonal therapy for reducing the incidence of neovascular glaucoma","volume":"86","author":"Toyama","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242966","article-title":"Visual outcomes of proton beam therapy for choroidal melanoma at a single institute in the Republic of Korea","volume":"15","author":"Jung","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9394(01)01142-4","article-title":"Efficacy of (123)N-isopropyl-p-[(123)I]-iodoamphetamine single photon emission computed tomography for the diagnosis of uveal malignant melanoma","volume":"132","author":"Goto","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0021","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2006.09.7816","article-title":"Particle radiation therapy using proton and heavier ion beams","volume":"25","author":"Schulz-Ertner","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0022","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. Available at: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf. Accessed June 5, 2024."},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0023","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0024","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41433-022-02178-0","article-title":"Proton beam radiotherapy for choroidal and ciliary body melanoma in the UK-national audit of referral patterns of 1084 cases","volume":"37","author":"Hussain","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0025","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/s41433-024-03035-y","article-title":"Comparing efficacy of charged-particle therapy with brachytherapy in treatment of uveal melanoma","volume":"38","author":"Tseng","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0026","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0360-3016(01)01560-7","article-title":"Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma","volume":"51","author":"Egger","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0027","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijrobp.2006.01.020","article-title":"Proton beam radiotherapy for uveal melanoma: Results of Curie Institut-Orsay proton therapy center (ICPO)","volume":"65","author":"Dendale","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0028","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijrobp.2009.07.1688","article-title":"Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years\u2019 experience","volume":"78","author":"Caujolle","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0029","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ajo.2003.12.032","article-title":"Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years\u2019 experience with beta-rays)","volume":"137","author":"Rouberol","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0030","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1016\/j.ijrobp.2011.05.012","article-title":"Stereotactic fractionated radiotherapy in the treatment of juxtapapillary choroidal melanoma: The McGill University experience","volume":"81","author":"Al-Wassia","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0031","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.ijrobp.2011.10.017","article-title":"Outcomes of proton radiation therapy for peripapillary choroidal melanoma at the BC Cancer Agency","volume":"83","author":"Tran","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0032","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ophtha.2004.11.038","article-title":"Ruthenium brachytherapy for uveal melanoma, 1979-2003: Survival and functional outcomes in the Swedish population","volume":"112","author":"Bergman","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102599","article-title":"Uveal melanoma: In the era of new treatments","volume":"119","author":"Wespiser","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0034","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.radonc.2010.03.023","article-title":"Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma","volume":"95","author":"Verschueren","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.survophthal.2022.05.002","article-title":"Laser treatment for choroidal melanoma: Current concepts","volume":"68","author":"Maheshwari","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0036","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00417-017-3834-3","article-title":"Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy","volume":"256","author":"Mahdjoubi","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0037","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ophtha.2004.09.028","article-title":"Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma","volume":"112","author":"Detorakis","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0038","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00417-017-3737-3","article-title":"Neovascular glaucoma after proton beam therapy of choroidal melanoma: Incidence and risk factors","volume":"255","author":"Riechardt","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0039","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bjophthalmol-2017-310801","article-title":"Predictors of radio-induced visual impairment after radiosurgery for uveal melanoma","volume":"102","author":"Gigliotti","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijrobp.2010.04.073","article-title":"Neovascular glaucoma after stereotactic radiotherapy for juxtapapillary choroidal melanoma: Histopathologic and dosimetric findings","volume":"80","author":"Fernandes","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0041","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0161-6420(87)33439-6","article-title":"Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation","volume":"94","author":"Seddon","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0042","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1186\/s12885-021-09002-0","article-title":"No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter","volume":"21","author":"Sabazade","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2024.10.008_bib0043","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ophtha.2020.06.030","article-title":"Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanoma","volume":"128","author":"Espensen","year":"2021","journal-title":"Ophthalmology"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624034758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624034758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:46:54Z","timestamp":1740134814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624034758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0360301624034758"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.008","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Outcomes of Ocular and Visual Preservation After Carbon Ion Radiation Therapy for Choroidal Malignant Melanoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}